These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21518144)

  • 1. Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patients.
    Garcia-Montojo M; De Las Heras V; Dominguez-Mozo M; Bartolome M; Garcia-Martinez MA; Arroyo R; Alvarez-Lafuente R;
    Eur J Neurol; 2011 Aug; 18(8):1027-35. PubMed ID: 21518144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive.
    Alvarez-Lafuente R; de las Heras V; García-Montojo M; Bartolomé M; Arroyo R
    Mult Scler; 2007 Jun; 13(5):578-83. PubMed ID: 17548435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.
    Simpson S; Taylor B; Dwyer DE; Taylor J; Blizzard L; Ponsonby AL; Pittas F; Dwyer T; van der Mei I
    Mult Scler; 2012 Jun; 18(6):799-806. PubMed ID: 22084489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-interferon treatment reduces human herpesvirus-6 viral load in multiple sclerosis relapses but not in remission.
    Alvarez-Lafuente R; De Las Heras V; Bartolomé M; Picazo JJ; Arroyo R
    Eur Neurol; 2004; 52(2):87-91. PubMed ID: 15273429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HHV-6 DNAaemia in patients with multiple sclerosis in Kuwait.
    Al-Shammari S; Nelson RF; Voevodin A
    Acta Neurol Scand; 2003 Feb; 107(2):122-4. PubMed ID: 12580862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-viral properties of interferon beta treatment in patients with multiple sclerosis.
    Hong J; Tejada-Simon MV; Rivera VM; Zang YC; Zhang JZ
    Mult Scler; 2002 May; 8(3):237-42. PubMed ID: 12120696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients.
    Alvarez-Lafuente R; Martinez A; Garcia-Montojo M; Mas A; De Las Heras V; Dominguez-Mozo MI; Maria Del Carmen C; López-Cavanillas M; Bartolome M; Gomez de la Concha E; Urcelay E; Arroyo R
    Eur J Neurol; 2010 Jan; 17(1):129-35. PubMed ID: 19659749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon beta treatment: bioavailability and antiviral activity in multiple sclerosis patients.
    Garcia-Montojo M; De Las Heras V; Bartolome M; Arroyo R; Alvarez-Lafuente R
    J Neurovirol; 2007 Dec; 13(6):504-12. PubMed ID: 18097882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of valacyclovir in multiple sclerosis.
    Friedman JE; Zabriskie JB; Plank C; Ablashi D; Whitman J; Shahan B; Edgell R; Shieh M; Rapalino O; Zimmerman R; Sheng D
    Mult Scler; 2005 Jun; 11(3):286-95. PubMed ID: 15957509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis.
    Behzad-Behbahani A; Mikaeili MH; Entezam M; Mojiri A; Pour GY; Arasteh MM; Rahsaz M; Banihashemi M; Khadang B; Moaddeb A; Nematollahi Z; Azarpira N
    J Microbiol Immunol Infect; 2011 Aug; 44(4):247-51. PubMed ID: 21524958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors.
    Ben Fredj N; Rotola A; Nefzi F; Chebel S; Rizzo R; Caselli E; Frih-Ayed M; Di Luca D; Aouni M
    J Neurovirol; 2012 Feb; 18(1):12-9. PubMed ID: 22058062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interferon-beta therapy on elements in the antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis.
    Petersen T; Møller-Larsen A; Ellermann-Eriksen S; Thiel S; Christensen T
    J Neuroimmunol; 2012 Aug; 249(1-2):105-8. PubMed ID: 22608883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotropic herpesviruses in multiple sclerosis.
    Hay KA; Tenser RB
    Mult Scler; 2000 Apr; 6(2):66-8. PubMed ID: 10773849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients.
    Alvarez-Lafuente R; García-Montojo M; De las Heras V; Bartolomé M; Arroyo R
    J Clin Virol; 2006 Dec; 37 Suppl 1():S24-6. PubMed ID: 17276363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity.
    Höllsberg P; Kusk M; Bech E; Hansen HJ; Jakobsen J; Haahr S
    Acta Neurol Scand; 2005 Dec; 112(6):395-402. PubMed ID: 16281923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short communication: treatment of relapsing-remitting multiple sclerosis 96 patients with IFN-beta 1b: results of a 6-year follow-up.
    Bencsik K; Füvesi J; Fricska-Nagy Z; Rajda C; Losonczi E; Török M; Vécsei L
    J Interferon Cytokine Res; 2006 Feb; 26(2):96-100. PubMed ID: 16487029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta1b in multiple sclerosis: effect on progression of disability and clinical markers of treatment response.
    Carmona O; Casado V; Moral E; Alonso-Magdalena L; Martínez-Yélamos A; Martínez-Yélamos S; Martín-Ozaeta G; Arbizu T
    Eur Neurol; 2008; 60(6):279-84. PubMed ID: 18824855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study.
    Boz C; Oger J; Gibbs E; Grossberg SE;
    Mult Scler; 2007 Nov; 13(9):1127-37. PubMed ID: 17967840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.
    Oikonen M; Laaksonen M; Aalto V; Ilonen J; Salonen R; Erälinna JP; Panelius M; Salmi A
    Mult Scler; 2011 Jun; 17(6):672-80. PubMed ID: 21212088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
    Dominguez-Mozo MI; Garcia-Montojo M; De Las Heras V; Garcia-Martinez A; Arias-Leal AM; Casanova I; Arroyo R; Alvarez-Lafuente R
    BMC Neurol; 2012 Sep; 12():107. PubMed ID: 23009575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.